LivaNova plc Stock
Price
Target price
€55.50
€55.50
0.910%
0.5
0.910%
€66.59
23.05.24 / Frankfurt
WKN: A14156 / Symbol: LIVN / Name: LivaNova / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
LivaNova plc Stock
LivaNova plc gained 0.910% compared to yesterday.
LivaNova plc is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 66 € there is a slightly positive potential of 18.92% for LivaNova plc compared to the current price of 55.5 €.
Pros and Cons of LivaNova plc in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | 0.910% | -2.632% | 8.824% | 36.029% | 18.590% | -16.541% | -13.281% |
| Neogen Corp. | 1.650% | 1.653% | 8.850% | -18.000% | -32.787% | -67.632% | -51.335% |
| Bio-Rad Labs Inc. A | 0.260% | -2.647% | 1.846% | -25.450% | -9.809% | -45.738% | - |
| Merit Medical Systems | -1.320% | 0.000% | 7.971% | -0.667% | 9.559% | 51.423% | 61.325% |
Comments
LivaNova PLC (NASDAQ: LIVN) had its price target raised by analysts at Mizuho from $75.00 to $80.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for LIVN provided by MarketBeat
News
LivaNova to Present at the Goldman Sachs Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs
LivaNova Reports First-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer (CINO), effective May 13, 2024. In